Cargando…
Alternative splicing of METTL3 explains apparently METTL3-independent m(6)A modifications in mRNA
N(6)-methyladenosine (m(6)A) is a highly prevalent mRNA modification that promotes degradation of transcripts encoding proteins that have roles in cell development, differentiation, and other pathways. METTL3 is the major methyltransferase that catalyzes the formation of m(6)A in mRNA. As 30% to 80%...
Autores principales: | Poh, Hui Xian, Mirza, Aashiq H., Pickering, Brian F., Jaffrey, Samie R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295969/ https://www.ncbi.nlm.nih.gov/pubmed/35853000 http://dx.doi.org/10.1371/journal.pbio.3001683 |
Ejemplares similares
-
Molecular basis for human mitochondrial tRNA m(3)C modification by alternatively spliced METTL8
por: Huang, Meng-Han, et al.
Publicado: (2022) -
DARS-AS1 recruits METTL3/METTL14 to bind and enhance DARS mRNA m(6)A modification and translation for cytoprotective autophagy in cervical cancer
por: Zhu, Miaohua, et al.
Publicado: (2022) -
Dissecting the effects of METTL3 on alternative splicing in prostate cancer
por: Wang, Lin, et al.
Publicado: (2023) -
METTL3-mediated m(6)A mRNA modification of FBXW7 suppresses lung adenocarcinoma
por: Wu, Yingtong, et al.
Publicado: (2021) -
METTL3 Is Involved in the Development of Graves’ Disease by Inducing SOCS mRNA m6A Modification
por: Song, Rong-hua, et al.
Publicado: (2021)